Fig 3. Plot of standardized mean differences among mTORi and MMF users within patients treated with TAC before and after propensity score (PS) matching.

Note. CsA: Cyclosporine; TAC: Tacrolimus; mTORi: Mammalian target of rapamycin inhibitors; MMF: Mycophenolate; IR: Incidence Rate; PY: Person-years; HR: Hazard ratio; 95%CI: 95% confidence interval; MACE: Major adverse cardiovascular events.